16^th Global Biomarkers and Clinical Research Summit

About Conference

Biomarkers in other words, biological markers deal with medical science being a source of identification and observation of varied underlying diseases. Observable signs are sometimes in contrast to medical symptoms, which are limited to those indications of health or illness perceived by patients themselves. They allow the assessment of those symptoms by a therapeutic interference thereby framing a pharmacological response.

We are delighted to welcome you to the prestigious 16th Global Biomarkers and Clinical Research Summit. Biomarkers 2020 brings together experts from all aspects to meet and discuss the future of Biomarkers &Clinical Research, Importance in today's world to thrive and survive with better health. The conference will be held on September 17 and 18 2020 at Vienna, Austria which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. We are optimistic that you will appreciate this upcoming Conference's Scientific Program

Vienna has been finalized as the venue for the summit and is full of tourist’s attraction places. We welcome participants from all over the globe to join us for the summit as well as to explore the beautiful city.

The attendees can build up the knowledge through exclusive sessions and panel discussions on latest innovations in Clinical Research & Vaccines and Drug Development

• Poster presentations by Young Researchers

• Keynote forums by Prominent Professors, Doctors

• Open Innovation Challenges

• Lectures from renowned speakers

• Novel techniques to benefit your research

• Global Networking sessions with 50+ Countries

 

Sessions/Tracks

Market Analysis

Industry Insights

The international market of Biomarkers was valued at around 40 billion USD in 2018 and is expected to increase by a CAGR of 13.7% by 2026. The major share of biomarkers is due to the advancements in biomarker based diagnostics.

The market of biomarkers is growing at an alarming rate due to the increase in the international diseases such as cancer, diabetes and Cardiovascular Diseases which are mainly caused due to the lifestyle changes like unhealthy diet, unhealthy lifestyle, lack of exercise and rest. The World health organization mentioned that these diseases contribute to around 50% of the total number of deaths annually.

Due to the advancements in technology, it is now possible to combine biomarkers with oral drugs to improve the accuracy of treatment. Biomarkers are also used to treat brain disorders and diseases by measuring the brain health over a period of time. Due to the recent advancements in biomarker treatments, the brain diseases can be treated with ease which results in cost cutting and early diagnosis of the patient.

The government is also proving a helping hand by providing initiatives to the patients and cutting the price of healthcare. It is also providing help by shifting their focus on early detection techniques and early cure of disease.

Disease Insights

The biomarkers market was led by the cancer section during 2018 followed by cardiovascular diseases and neurological diseases. This shows that there is an ever increasing demand for diagnostic requirements for cancer cure. The future market is expected to grow in the personalized medicine and strategic medicine field.

 

Past Conference Report

Biomarkers Summit 2019

16 th Global Biomarkers Summit was held during March 20-21, 2019 at Paris, France, which was an extraordinary achievement. Discernible keynote speakers from multitudinal assumed establishments and affiliations kept an eye on the get-together with their splendid proximity. The respected guests, keynote speakers and masters shared their innovative investigation and boundless experience data and palaver on various latest and embraces different research aspects with focus to accelerate scientific discoveries and major milestones of Biomarkers Event

This conference has been directed to the straight and the point out goal of advancing the advancements of new recognitions and thoughts for investigating the abnormal state of learning came to by academic group on Biomarkers Summit 2019. This celebrated event facilitated by Organizing Committe Members was set apart with the participation of youthful and splendid specialists, scientists, researchers, business delegates and gifted understudy groups.

The meeting was sorted out around the subject “Challenges and opportunities in incorporating Biomarker research”. The determined and pertinent learning shared, will in like manner urge legitimate joint endeavors to sustain logical increasing speeds.

Biomarkers Summit 2019 also acknowledges the help of the Honorable Chair Kazuko Tatsumura, Gaia Holistic Health, USA whose support brought this event to its grand success.

The eminent personalities in the conference were:

Kazuko Tatsumura, Gaia Holistic Health, USA

Indira Poola, Silbiotech Inc., USA

Keson Trakunram, Prince of Songkla University, Thailand

Aylin Erol, Dokuz Eylul University, Turkey

Rim Bouchelaghem, Universite Badji Mokhtar, Algeria

Workinesh Daba, Addis Ababa University, Ethiopia

Manikonda Prakash Rao, Osmania University, India

Charles Wiseman, Briacell Therapeutics, USA

Valentina R. Dikova, University of Valencia, Spain

Pritsana Raungrut, Prince of Songkla University, Thailand

Ramy Elashry, Mansoura University, Egypt

Rim Bouchelaghem, Universite Badji Mokhtar, Algeria

Workinesh Daba Seboka, Addis Ababa University, Ethiopia

 

We are pleased to announce our forth coming conference 15th Global Biomarkers and Clinical Research Summit to be held in Vienna, Austria, during September 17-18, 2020 

For more details visit: https://biomarkers.global-summit.com/

 

                                           Let us meet again @ Biomarkers Summit 2020

 

 

Past Reports  Gallery